Xu Yao Selected Research

Xu Yao Research Topics

Disease

10	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 12/2007
9	Inflammation (Inflammations) 11/2022 - 08/2016
7	Neoplasms (Cancer) 07/2022 - 01/2014
6	Atopic Dermatitis (Atopic Eczema) 04/2022 - 01/2017
5	Dermatitis 11/2022 - 03/2017
4	Breast Neoplasms (Breast Cancer) 10/2022 - 07/2020
4	Skin Diseases (Skin Disease) 01/2022 - 08/2016
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2010 - 06/2005
3	Chronic Urticaria 01/2022 - 03/2011
3	Infections 01/2015 - 07/2011
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 10/2010
2	Headache (Headaches) 08/2016 - 05/2016
2	Human Influenza (Influenza) 10/2015 - 07/2011
2	Frailty 07/2011 - 02/2011
1	Triple Negative Breast Neoplasms 10/2022
1	Retinoblastoma (Glioblastoma, Retinal) 10/2022
1	Carcinogenesis 10/2022
1	Rupture 02/2022
1	Tympanic Membrane Perforation 01/2021
1	Alcoholic Cardiomyopathy 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Malaria 12/2020
1	Cholesteatoma 04/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Papillary Thyroid Cancer 01/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	HIV Infections (HIV Infection) 06/2018
1	Hypersensitivity (Allergy) 12/2017
1	Asthma (Bronchial Asthma) 12/2017
1	Intestinal Perforation 02/2017
1	Fistula 02/2017
1	Contact Dermatitis (Eczema, Contact) 10/2016
1	Cadaver (Cadavers) 08/2016

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 11/2022 - 03/2011
4	Biological ProductsIBA 10/2022 - 01/2014
4	Immunoglobulin E (IgE)IBA 01/2022 - 04/2016
3	Imiquimod (Aldara)FDA LinkGeneric 11/2022 - 03/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 06/2018
3	Immunoglobulin G (IgG)IBA 01/2022 - 12/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 09/2010
3	AllergensIBA 01/2020 - 04/2016
2	TransglutaminasesIBA 11/2022 - 01/2020
2	GenisteinIBA 01/2022 - 01/2022
2	Tamoxifen FDA LinkGeneric 01/2022 - 01/2022
2	calcipotriene (calcipotriol)FDA LinkGeneric 01/2021 - 01/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2020 - 01/2019
2	Tryptophan (L-Tryptophan)FDA Link 12/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2016
2	InflammasomesIBA 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 07/2016 - 10/2006
2	Interferon gamma ReceptorIBA 10/2007 - 06/2005
1	Small Interfering RNA (siRNA)IBA 11/2022
1	Cysteamine (Mercaptamine)FDA Link 11/2022
1	Carrier Proteins (Binding Protein)IBA 10/2022
1	InterferonsIBA 07/2022
1	pimecrolimus (Elidel)FDA Link 04/2022
1	CellulaseIBA 02/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	anti-thyroid autoantibodiesIBA 01/2022
1	FluorineIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022
1	MetalsIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	CollagenIBA 01/2021
1	schizandrin BIBA 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	TransferasesIBA 01/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2020
1	ArtesunateIBA 12/2020
1	Immunoglobulin A (IgA)IBA 11/2020
1	secukinumabIBA 11/2020
1	ResveratrolIBA 07/2020
1	Estradiol Congeners (Synthetic Estrogens)IBA 07/2020
1	Diethylstilbestrol (Stilbestrol)FDA Link 07/2020
1	Estrogens (Estrogen)FDA Link 07/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2020
1	Vitamin D FDA LinkGeneric 04/2020
1	Neuroprotective AgentsIBA 01/2020
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2020
1	Diphtheria ToxinIBA 03/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2017
1	SteroidsIBA 02/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2017
1	dupilumabIBA 01/2017
1	CD100 antigenIBA 10/2016
1	CateninsIBA 08/2016
1	ProgranulinsIBA 08/2016

Therapy/Procedure

4	Therapeutics 07/2022 - 06/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2020
2	Acupuncture Points (Acupuncture Point) 08/2016 - 10/2014
2	Aftercare (After-Treatment) 05/2016 - 10/2014
1	Emergency Treatment 01/2022
1	Premedication 01/2022
1	Contraindications 04/2020
1	Electroacupuncture 01/2020